Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
BOSTON, Dec. 29, 2023 Pyxis Oncology, Inc. , a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis.
Dr. Kobayashi brings over 25 years of experience in oncology drug development, including Antibody Drug Conjugates and other oncology modalitiesBOSTON, Nov. 28, 2023 Pyxis Oncology, Inc. , a.
Form 8-K Pyxis Oncology, Inc. For: Nov 27 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Pyxis Oncology (PYXS) to Acquire Apexigen (APGN) for $0.64/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.